FDA Advisers Consider Novavax COVID-19 Vaccine This Week

Canada News News

FDA Advisers Consider Novavax COVID-19 Vaccine This Week
Canada Latest News,Canada Headlines
  • 📰 WebMD
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

The FDA’s vaccine advisors are scheduled to meet on Tuesday to consider authorizing the Novavax COVID-19 vaccine.

on Friday, saying that the rate of myocarditis is “within the expected rate” and similar to the groups that received a placebo. The company added there is “insufficient evidence” to establish a causal relationship between the vaccine and myocarditis or pericarditis.

“We have learned that we can expect to see natural background events of myocarditis in any sufficiently large database, and that young males are at higher risk,” the company said. “Myocarditis is most often caused by nonspecificIn the FDA briefing document, the agency summarized that the “known benefits” among Novavax vaccine recipients relative to the placebo include a “reduction in the risk of mild to severe COVID-19 occurring at least 7 days after the second primary series vaccination.

In addition, the vaccine is seen as another option for those who remain unvaccinated. Novavax developed a protein subunit vaccine, which is a more traditional type than the mRNA technology used for the Moderna and Pfizer shots. Other well-known subunit vaccines include the

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WebMD /  🏆 709. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. FDA flags risk of heart inflammation after Novavax COVID vaccineU.S. FDA flags risk of heart inflammation after Novavax COVID vaccineThe U.S. Food and Drug Administration hasraised concerns about a possible risk of heart inflammation from Novavax Inc's COVID-19 vaccine, even as the company's data showed it could reduce the chances of mild-to-severe disease.
Read more »

U.S. FDA flags risk of heart inflammation after Novavax COVID vaccineU.S. FDA flags risk of heart inflammation after Novavax COVID vaccineThe U.S. Food and Drug Administration hasraised concerns about a possible risk of heart inflammation from Novavax Inc's COVID-19 vaccine, even as the company's data showed it could reduce the chances of mild-to-severe disease.
Read more »

COVID-19 Vaccines For Kids Under 5 Could Be Ready By June 21COVID-19 Vaccines For Kids Under 5 Could Be Ready By June 21'Our expectation is that within weeks, every parent who wants their child to get vaccinated will be able to get an appointment.'
Read more »

A Tiny Change in Jab Strategy Might Reduce COVID-19 Vaccine Fatigue, Mouse Study FindsA Tiny Change in Jab Strategy Might Reduce COVID-19 Vaccine Fatigue, Mouse Study FindsFirst there's weakness and throbbing in the arm muscles that take on the immune-teaching chemicals. Then the fatigue and aches spread until your whole body is complaining.
Read more »

Missions cancel weekend games after positive COVID-19 testsMissions cancel weekend games after positive COVID-19 testsSaturday’s game against Tulsa was called off about an hour before the scheduled first...
Read more »



Render Time: 2025-03-04 12:59:19